1.新聞網址︰
※ 網址超過一行 請縮網址 ※
https://www.wionews.com/india-news/pfizer-and-moderna-dont-want-to-deal-with-indian-states-for-vaccines-387168
https://reurl.cc/83nLdM
2.新聞來源︰
WION
世界一體新聞台
3.完整新聞標題
※ 請完整轉載標題 請勿修改與編排 ※
Pfizer and Moderna don't want to deal with Indian states for vaccines
輝瑞和莫德納不想就疫苗與印度各州打交道
4.完整新聞內容︰
※ 請完整轉載原文 請勿修改內文與編排 ※
When the Indian government allowed states to pursue their own vaccine
procurement, the idea was welcomed.
印度政府允許各州自行採購疫苗之政策受到歡迎。
States governments were quick to seize the moment. Some chief ministers
announced global tenders to buy shots from the international market. Weeks
later, they are complaining again.
各州政府很快抓住了時機。各州首席部長宣布從國際市場購買鏡頭的全球招標，但幾
週後，他們再次抱怨。
Because companies like Pfizer and Moderna don't want to deal with them. They
want to negotiate directly with the centre and set the terms.
因為像輝瑞和莫德納這樣的公司並不想與其打交道。這些公司想直接與中央政府談判
並約定條款。
It's not just about the money. They want the kind of guarantees that India
hasn't given any vaccine maker.
這不僅僅是錢的問題，這些公司想要印度政府從未給過任何疫苗製造商的保證。
So what do these vaccine majors need from India?
那麼這些疫苗大廠想要從印度政府得到什麼？
Pfizer and Moderna are among the best shots on the international market. Both
vaccines work on the same technology. They are more than 90 per cent
effective. Together, they have been approved by more than 40 countries. India
wants them too. But on its own terms.
輝瑞和莫德納是國際市場上最好的標的之一。兩種疫苗都採用相同的技術，其疫苗有
效性超過 90%，也都同時得到了 40 多個國家的批准。印度也想要這些疫苗，但前提
必須是符合其自身要求。
The government has authorised states to negotiate for themselves. Global
tenders were announced. But it proved to be a damp squib as vaccine makers
refused to deal with state governments.
政府已授權各州自行談判，各州亦宣布全球招標。但事實證明，由於疫苗製造商拒絕
與州政府打交道，因此這種方式已被證明是無稽之談。
Punjab made request to Moderna, it was denied. Moderna says it will only deal
with the central government.
旁遮普省向摩德納提出要求但被拒絕。莫德納表示只會與中央政府打交道。
The Delhi state government wrote to Moderna, Pfizer and Johnson and Johnson.
It got the same reply. They will only deal with the Government of India.
德里州政府寫信給莫德納、輝瑞和嬌生，也得到了同樣的答覆，其只會與印度中央政
府打交道。
Beyond the obvious need of approvals and clearances, these vaccine companies
have their own demands.
明顯地，除了需要批准和許可之外，這些疫苗公司還有自身其他要求。
For instance, Pfizer CEO claims that they have been trying to get Pfizer
vaccines to India for months. But Pfizer wants indemnity, a legal exemption
from future lawsuits over their vaccines. Countries like the US and Britain
have signed such clauses.
例如，輝瑞公司的首席執行官聲稱，他們幾個月來一直在試圖將輝瑞疫苗進口至印度
。但輝瑞公司想要將來對其疫苗訴訟的法律豁免，而美國和英國等國家已經簽署此類
條款。
It basically means that if the vaccine maker is sued in India, it will be the
government's problem, not the company's. India has not given such indemnity
to any vaccine producer. Why should Pfizer be the exception?
這基本上表示著，如果疫苗製造商於印度被起訴，那將是政府的問題，而與疫苗公司
無關。目前印度政府尚未向任何疫苗生產商提供此類免責條款，那為何輝瑞可以例外
？
The discussion is still on between the company and the government. In the
past, Pfizer has been accused of bullying Latin American countries. They
demanded embassy buildings and military bases as guarantee against the cost
of any future legal cases.
疫苗公司與政府之間的討論仍持續進行。而過去輝瑞曾被指責欺凌拉美國家，其要求
大使館建築和軍事基地作為未來任何法律案件費用的保證。
The other problem is supply. Rich countries have already taken most of the
shots off the shelves. Reports say, Moderna has its hands full with the
existing orders. It might not have more doses for India. According to a
report in April, Moderna already had orders to supply more than 1,000 million
doses. These are for countries like the US, the EU, Canada, Japan,
Switzerland and others.
另一個問題是供應問題。富裕國家已經取得了大量提供，報導稱，莫德納忙於處理現
有訂單。其可能不會為印度提供更多劑量。根據 4 月份的一份報告，莫德納已經接到
超過 10 億劑的供應訂單，以提供於美國、歐盟、加拿大、日本、瑞士等國家。
Moderna is planning a major expansion in manufacturing. But even with a
global tender, India may have to wait in line for its deliveries.
莫德納正計劃大規模擴張製造能量。但即使有全球招標，印度也可能不得不排隊等候
交貨。
States like, Maharashtra, Uttar Pradesh, Tamil Nadu, Kerala and Karnataka
have issued global tenders. But all of them are waiting for a bid.
馬哈拉施特拉邦，北方邦，泰米爾納德邦，喀拉拉邦和卡納塔克邦等州已經發布了全
球招標，但這些州也都在等待賣方。
5.附註、心得、想法︰
※ 40字心得、備註 ※
這一篇講的比較清楚，
1. 輝瑞、莫德納、嬌生都拒絕地方政府的採購。
2. 拒絕的主因原因在於藥害救濟的問題，這也是地方政府跟個人都無法解決的。
3. 訂單滿載，除非有特別的原因不然很難插隊。
其實我是蠻期待地方政府自己去洽談，民間團體願意盡力，且有管道可以購得國際原
廠疫苗的話，不過輝瑞、莫德納跟嬌生都表示只跟國家以及超國家團體簽約，在這種
情況下還可以取得的，我想應該是非常厲害，而不是TAMAMA。
https://reurl.cc/qg86Ry
※ 「Live」、「新聞」、「轉錄」此類文章每日發文數總上限為3篇，
自刪與板主刪除，同樣計入額度 ※